Yogiraj Ray - Concepedia

Author

Yogiraj Ray

Indian Institute of Chemical Biology ORCID

Also Known As

R Goswami, Rudra Prosad Goswami, Y Ray, Y. Ray, YOGIRAJ RAY, Yogiraj Ray

Publications

540

Citations

H-Index

Concepts

All Affiliations

Indian Institute of Chemical Biology Indian Institute of Tropical Meteorology Medical College and Hospital, Kolkata Institute of Genomics and Integrative Biology Academy of Scientific and Innovative Research

About

Yogiraj Ray is an author at Indian Institute of Chemical Biology specializing in covid-19, immunology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	87
2	Immunology	3	3	87
3	Humoral Immunity	2	2	74
4	Pathology	1	1	13
5	Clinical Trials	1	1	58

Yogiraj Ray

Publications

351

Citations

H-Index

Page 1

	Year	Citations
Nature and Dimensions of Systemic Hyperinflammation and its Attenuation by Convalescent Plasma in Severe COVID-19 Purbita Bandopadhyay, Ranit D’Rozario, Abhishake Lahiri, The Journal of Infectious Diseases	2021	98
Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma Hyung Park, Thaddeus Tarpey, Mengling Liu, JAMA Network Open	2022	65
Clinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial Yogiraj Ray, Shekhar Ranjan Paul, Purbita Bandopadhyay, Viral DiagnosticsImmunodeficienciesPassive ImmunizationImmunologySevere Covid-19 Patients	2020	58
A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19 Yogiraj Ray, Shekhar Ranjan Paul, Purbita Bandopadhyay, Nature Communications	2022	40
Testing urine samples with rK39 strip as the simplest non-invasive field diagnosis for visceral leishmaniasis Sukhen Das, Yogiraj Ray, Md. Mustafizur Rahman Journal of Postgraduate Medicine	2012	17
Nature and dimensions of the cytokine storm and its attenuation by convalescent plasma in severe COVID-19 Purbita Bandopadhyay, Ranit D’Rozario, Abhishake Lahiri, Randomized Control TrialLung InflammationImmunodeficienciesImmunologyImmune Regulation	2020	16
Circulating Interleukin-8 Dynamics Parallels Disease Course and Is Linked to Clinical Outcomes in Severe COVID-19 Ranit D’Rozario, Deblina Raychaudhuri, Purbita Bandopadhyay, Viruses	2023	14
Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19 Jafar Sarif, Deblina Raychaudhuri, Ranit D’Rozario, Frontiers in Immunology ImmunologyViral PathogenesisPathologyPathogenic Plasma ProteomeImmune Dysregulation	2021	13
Protective Efficacy of Secondary Prophylaxis Against Visceral Leishmaniasis in Human Immunodeficiency Virus Coinfected Patients Over the Past 10 Years in Eastern India Rama Prosad Goswami, Rudra Prosad Goswami, Ayan Basu, American Journal of Tropical Medicine and Hygiene	2016	10
Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19 Daizee Talukdar, Purbita Bandopadhyay, Yogiraj Ray, Gut Pathogens	2023	10

Page 1